Overview

We are a biotechnology company developing advanced spinal stem cell therapeutics to treat patients with diseases of the intervertebral disc.

Our Impact

With back pain being such a significant problem globally and a burden on the healthcare system, our technology has the potential to increase quality of life for patients and to reduce costs to the healthcare system. 

A Unique Tool to Battle Back Pain

DiscGenics is the only company to utilize allogeneic therapeutic progenitor cells derived from intervertebral disc within the spine to treat the disc. A progenitor cell is a partially differentiated adult stem cell. We have a patented technology for isolating cells directly from adult human disc tissue and expanding these cells into our proprietary Discogenic Cells.

Discogenic Cells